SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Acquired by Capital Square LLC

Capital Square LLC increased its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 25.3% during the 4th quarter, HoldingsChannel.com reports. The fund owned 2,700 shares of the exchange traded fund’s stock after purchasing an additional 546 shares during the period. Capital Square LLC’s holdings in SPDR S&P Biotech ETF were worth $250,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of XBI. Demars Financial Group LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter valued at approximately $280,309,000. Mirae Asset Securities USA Inc. grew its holdings in SPDR S&P Biotech ETF by 66.7% during the 4th quarter. Mirae Asset Securities USA Inc. now owns 1,500,000 shares of the exchange traded fund’s stock valued at $135,090,000 after purchasing an additional 600,000 shares in the last quarter. Bessemer Group Inc. grew its holdings in SPDR S&P Biotech ETF by 5.7% during the 4th quarter. Bessemer Group Inc. now owns 1,376,834 shares of the exchange traded fund’s stock valued at $123,997,000 after purchasing an additional 73,866 shares in the last quarter. Proficio Capital Partners LLC lifted its holdings in SPDR S&P Biotech ETF by 16,156.1% in the 4th quarter. Proficio Capital Partners LLC now owns 917,329 shares of the exchange traded fund’s stock worth $82,615,000 after buying an additional 911,686 shares in the last quarter. Finally, Employees Retirement System of Texas boosted its position in SPDR S&P Biotech ETF by 33.6% in the 4th quarter. Employees Retirement System of Texas now owns 877,272 shares of the exchange traded fund’s stock valued at $79,007,000 after buying an additional 220,400 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA XBI opened at $75.93 on Friday. SPDR S&P Biotech ETF has a 1 year low of $66.66 and a 1 year high of $105.47. The stock’s 50-day simple moving average is $84.02 and its 200-day simple moving average is $91.31. The firm has a market cap of $4.79 billion, a price-to-earnings ratio of 11.47 and a beta of 1.00.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.